Audio
An Interview with Support Group Leader Valarie Traynham
A Myeloma Patient’s Journey from Receiving a Myeloma Diagnosis to Leading a Support Group
In this episode of the A Day in the Life Podcast, 7-year multiple myeloma survivor and support group leader Valarie Traynham discusses…
Page
Blood Cancer United Co-Pay Assistance Program Blood Cancer United's Co-Pay Assistance Program works to remove financial barriers toward the cost of…
News Article
The 4th Annual Schleicher’s Hikers 5K Walk/Run was held on Saturday, October 8 in the town of Bel Air in Harford County, MD. Sponsored by Schleicher’s Hikers and Ravens Roost #74 of Harford County, MD, the annual event was able to successfully raise $11,311 for the International Myeloma…
Page
In the U.S., African Americans are about 14% of the country's population, but they constitute about 20% of all myeloma patients. And that incidence is actually growing. This is an enormous burden, considering 1 in every 5 patients diagnosed with multiple myeloma in the U.S. is African American.…
Page
What Are Disparities in Healthcare?
For people living with multiple myeloma, disparities in healthcare can spell the difference between early diagnosis and early treatment. Understanding these preventable differences is key to bridging the gap toward achieving multiple myeloma health…
Videos
What Is Minimal Residual Disease (MRD)?
Myeloma expert Dr. Brian G.M. Durie discusses what MRD is, and what it means to be MRD negative.
The BOTTOM LINE: MRD at 10-6 means negative after checking a million cells, and MRD at 10-5 means negative after checking 100,…
Page
Myeloma knows no borders—people everywhere are affected by this complex disease.
Videos
M-POWER New York Virtual Webinar
Watch the Replay
Know the risks and symptoms of multiple myeloma, the most common blood cancer in African Americans, and how to get the best care.
The IMF M-Power Initiative is focused on…
News Article
CLARK, N.J., Sept. 29, 2022 -- The Annual Miracles for Myeloma 5K Hybrid Run/Walk will be celebrating its tenth anniversary this year. For the past nine years, this annual event has raised over $700,000 and has funded eight Brian D. Novis (BDN) Research Grants.…
News Article
In this article from Blood and Life Sciences Magazine, IMF's Chief Medical Officer Joseph Mikhael, MD, talks about new treatments available for multiple myeloma and how the…
Audio
You're listening to A Day in the Life Podcast, brought to you by the International Myeloma Foundation. We hope this podcast provides messages of hope and resilience, for those in the Myeloma Community and beyond.
Today we are talking to Andy Sninsky, who was diagnosed with multiple myeloma in…
Event
I will be running the Chicago marathon on October 9th to raise funds for the IMF.
Videos
Do You Know Myeloma?
During the 2022 IMF Support Group Leaders Summit, we asked patients and care providers what they wished people knew about multiple myeloma.
Videos
Common Support Needs and Coping Skills for Myeloma Patients
IMF Vice President of Support Groups Robin Tuohy will moderate a presentation by Elaine Wheat Dawson, Psy.D (City of Hope—Duarte, CA)
Dr. Elaine Wheat Dawson is a Clinical Psychologist and Assistant Clinical Professor in the…
Videos
Should Patients Consult with a Myeloma Specialist?
Myeloma expert Dr. Brian G.M. Durie discusses if it is important for patients to see a multiple myeloma specialist.
The BOTTOM LINE: Patients should consult with a myeloma expert. The IMF InfoLine can assist with finding a…
IMF Person
Rebecca Lu brings extensive experience in multiple myeloma and plasma cell dyscrasias, having worked first in outpatient clinical care before moving into research, where she was instrumental in building the foundation of the myeloma research program. Her background spans clinical trial conduct,…
News Article
NEW YORK, Sept. 15, 2022 – The International Myeloma Foundation (IMF) today announced that it is collaborating with Memorial Sloan Kettering Cancer Center (MSK) in New York City to launch M-Power New York—a program designed to empower people to change the course of myeloma by…
Event
I hope everyone reading this will please consider donating to continue on-going research and development of new treatments to keep those battling with multiple myeloma healthy for many more years.
The next race I will be running is the United Airlines NYC Half Marathon on Sunday March 19, 2023.
News Article
On Thursday evening, September 1, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky signed off on the CDC’s recommendation to administer the updated Moderna and Pfizer-BioNTech Bivalent COVID-19 vaccines to Americans this fall,…
Videos
Are COVID-19 Prevention Measures Still Necessary?
Myeloma expert Dr. Brian G.M. Durie discusses if myeloma patients should continue practicing prevention measures to avoid contracting the COVID-19 infection.
The BOTTOM LINE: Myeloma patients should continue to…
News Article
STUDIO CITY, CA, AUGUST 31, 2022 – September is Blood Cancer Awareness Month. This year, the International Myeloma Foundation (IMF) is bringing multiple myeloma—the second most common type of blood cancer—to the forefront through its #kNOwMyeloma campaign.…
Event
I have been doing these awareness and fundraising rides concerning Multiple Myeloma since 2011. With each mile of these rides on 3 continents, I have carried this cancer in me. I do not know why it has not taken me yet, but each bicycle mile is a gift that makes me happy.
Page
The latest news updates on COVID-19 and CDC guidelines for myeloma patients and the moderately and severely immunocompromised.
June 23, 2025
New COVID-19 Variant NB.1.81 Causes ‘Razor Blade Throat’
According to a…
Page
To prevent a COVID-19 infection, the CDC advises improving ventilation in your home.
Good ventilation means filtering the air inside your house, getting fresh air in, and improving air…
Page
CDC Updated Recommendations for Moderately or Severely Immunocompromised Individuals
On October 19, the U.S. Centers for Disease Control and Prevention (CDC) updated its…
News Article
Read the Healthline Article: How to Talk with Others About Your Multiple Myeloma Diagnosis
In this Healthline article published August 17, 2022, IMF Patient, President, and CEO Yelak Biru says; “If you don’t have that conversation, there’s going to be a mismatch in my ability to receive…
News Article
On Thursday, August 11, the Center for Disease Control and Prevention (CDC) streamlined its COVID-19 guidance for the public to better…
Videos
What Do Care Providers Need To Know About CAR T-Cell Therapy?
Multiple myeloma expert Dr. Brian G.M. Durie discusses what care providers should know about CAR T-cell therapy.
The BOTTOM LINE: Patients and their care providers should discuss carefully with their medical team…
News Article
On Wednesday, August 10, Bristol Myers Squibb and 2seventy bio, Inc. announced the positive topline results from KarMMa-3—a Phase 3, global, randomized, multicenter, open-label study evaluating ABECMA® (idecabtagene vicleucel) compared to standard combination regimens in adults…
Page
Multiple Myeloma and Plasma Cell Disorders: Update On Diagnosis, Prognosis, Treatment, and Supportive Care
This supplement to JADPRO has been developed by members of the International Myeloma Foundation (IMF) Nurse Leadership Board.
News Article
On Friday, July 29, Laughs 4 Life returned to Hattiesburg, MS. This year’s successful event featured comedian Leanne Morgan and special guests, James Austin Johnson and Keith Alberstadt and was held at the Hattiesburg Saenger Theater—with over 1,000 attendees!
The International…
Audio
In Memoriam
During his life, Nick Lenoir made every attempt to share his story of his multiple myeloma journey to give hope to others in the community. In this podcast, Nick says about the disease, "How you approach it and how you cope with it is going to be different, as well as how the myeloma…
News Article
By Robin Levy IMF Senior Director, Public Policy & AdvocacyThere are many new ideas in the cancer public policy space, with two proposals to help cancer patients being discussed most frequently: President Biden’s Cancer Moonshot initiative and the creation of a new agency known as ARPA-H…
News Article
Support the International Myeloma Foundation's Mission through Your Legacy
By Lynn K. Green, Ed.D.
IMF Senior Vice President, Philanthropy
The mission of the International Myeloma Foundation (IMF) is to improve the quality of life of myeloma patients while working toward prevention…
Author
Serdar Erdoğan
Director, Global Myeloma Action Network and European & Middle Eastern Patient Programs
Serdar joined the IMF in September 2018 with seven years of experience in the non-profit sector, specializing in corporate communications and development. For the prior four…
News Article
Page
The following videos, presented by Medscape Oncology, are designed for healthcare practitioners to earn continuing education (CE) credits.
In this CE program, nurses from the IMF's Nurse Leadership Board (NLB) present new drugs, regimens, and strategies for multiple myeloma.
Videos
Should myeloma patients undergo mass spectrometry testing?
Myeloma expert Dr. Brian G.M. Durie discusses if mass spectrometry is ready for commercial use.
The BOTTOM LINE: With a better understanding and commercial availability, mass spectrometry will be a powerful…
Page
Presented by Medscape Oncology, this activity is designed for continuing medical education (CME) credits. Moderated by Dr. Brian G.M. Durie (Chief Scientific Officer and Chairman of the Board of the International Myeloma Foundation), this activity features myeloma expert Dr.…
Videos
This M-Power Charlotte virtual myeloma workshop includes:
Learn about multiple myeloma, a disease more than twice as common in people of African descent as in whites. From “Myeloma for Patients Who Are Just Getting Started” to…
Videos
African American SMM Patients Presented at EHA 2022
Dr. Malin Hultcrantz Discusses African American SMM Patients Having Lower Risk of Progression Compared to White SMM Patients at EHA22
Abstract Title:
African American patients with smoldering multiple myeloma may have a lower risk of…
Videos
What Patients and Caregivers Need to Know About Immunotherapy, Bispecific Antibodies, and CAR T-cell Therapy
Speakers
Donna Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health System, IMF Nurse Leadership)
Tom Martin, MD (University of California San Francisco)…
News Article
Top cancer researchers from across the globe gathered this year for the annual American Society of Clinical Oncology (ASCO) Meeting and European Hematology Association (EHA) Congress. The International Myeloma Foundation (IMF) team is providing these lecture-type video presentations to keep you…
Videos
Making Sense of Myeloma Treatment
At the IMWG Conference Series, “Making Sense of Treatment,” leading myeloma experts discussed the latest drug therapy news from the June 2022 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the…
Audio
A Day in the Life: Terrence and Toni Green's Myeloma Journey
You're listening to A Day in the Life Podcast, brought to you by the International Myeloma Foundation. We hope this podcast provides messages of hope and resilience for those in the myeloma community and beyond. Today we're talking to…
News Article
LOS ANGELES, CA, JUNE 8, 2022—The International Myeloma Foundation (IMF) is proud to announce the recipients of this year's Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award, which will be presented in an in-person awards ceremony today, June 8th,…
Videos
Should patients start bone therapy while in remission?
Myeloma expert Dr. Brian G.M. Durie discusses if patients should start bone therapy while in remission.
The BOTTOM LINE: Talk to your doctor about your situation. Myeloma patients who are in deep…